Published in TB and Outbreaks Week, July 26th, 1999
In this study, researcher C. Manca and colleagues from New York's Rockefeller University and the U.S. National Institutes of Health examined M. tuberculosis CDC1551, a clinical isolate reported to be hypervirulent and to grow faster than other isolates. They compared the isolate with two other clinical isolates (HN60 and HN878) and two laboratory strains (H37Rv and Erdman) ("Mycobacterium tuberculosis CDC1551 Induces a More Vigorous Host Response in vivo and in vitro, But is Not More...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.